The advent
of human - induced pluripotent stem cell (hiPSC) technology has provided a unique opportunity to establish cellular models
of disease from individual
patients, and to study the effects
of the underlying genetic aberrations upon multiple different cell
types, many
of which would not normally be
accessible.